Aktis Oncology, Inc. Common stock (AKTS) Stock Price
Aktis Oncology, Inc. Common stock (NASDAQ: AKTS) last traded at $24.07, up 0.29% on the session. The quote above updates while this page is open; the figures below are drawn from Aktis Oncology, Inc. Common stock’s own filings and are restated only when a new one is published.
Aktis Oncology, Inc. Common stock (AKTS) company overview
Aktis Oncology, Inc. Common stock trades on NASDAQ under the ticker AKTS. Its market capitalisation is $1.29 billion.
AKTS valuation
Valuation measures for Aktis Oncology, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
Market cap
$1.29B
Enterprise value
$1.28B
Price / book
2.65
Beta
1.60
AKTS financials
Trailing-twelve-month figures tagged in Aktis Oncology, Inc. Common stock's XBRL filings with the SEC.
Cash
$82.49M
AKTS trading statistics
Range and volume for AKTS over the past 52 weeks.
52-week high
$34.19
52-week low
$14.72
Volume
221.3K
Average volume
364.6K
Previous close
$24.00
Aktis Oncology, Inc. Common stock (AKTS) FAQs
What is the AKTS stock price today?
Aktis Oncology, Inc. Common stock (AKTS) last traded at $24.07, up 0.29% on the session. FurlPay quotes AKTS from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is AKTS listed on?
Aktis Oncology, Inc. Common stock is listed on NASDAQ under the ticker symbol AKTS.
What is Aktis Oncology, Inc. Common stock's market cap?
Aktis Oncology, Inc. Common stock has a market capitalisation of $1.29 billion, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is AKTS's 52-week range?
Over the past 52 weeks AKTS has traded between $14.72 and $34.19.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0002035832).
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
AKTS Stock Price & Quote | Aktis Oncology, Inc. Common stock | FurlPay